Composition: Flurbiprofen 8.75mg.
Presentation: Cherry flavour lozenge.
Storage and stability: Store below 25C in a dry place.
Action: Non-steroidal anti-inflammatory drug (NSAID).
Indications: Symptomatic relief of sore throat.
Contraindications: Hypersensitivity to flurbiprofen, aspirin and other NSAIDs or other lozenge ingredients. Existing or history of peptic ulceration. History of bronchospasm, rhinitis and urticaria associated with aspirin and other NSAIDs.
Dosage and administration: For adults and children over the age of 12 years only. Suck or dissolve one lozenge slowly in the mouth every three to six hours as required; maximum of five lozenges in 24 hours. The lozenges are recommended to be used for a maximum of three days. To avoid local irritation, the lozenges should be moved around the mouth while sucking.
Pregnancy and lactation, avoid use in the last three months of pregnancy. Flurbiprofen appears in breast milk in very low concentrations and is unlikely to adversely affect the breast-fed infant.
Elderly, no dose modification required.
Overdosage: Symptoms may include nausea, vomiting, headache, drowsiness, blurred vision and dizziness. Treatment should consist of gastric lavage and correction of serum electrolytes if necesary.
Precautions: As for oral flurbiprofen products. Flurbiprofen lozenges should not be taken with any other NSAIDs.
Drug interactions: As for oral flurbiprofen products.
Side effects: Dyspepsia, nausea, vomiting, gastrointestinal haemorrhage, diarrhoea, mouth ulcers, fluid retention, oedema and exacerbation of peptic ulceration and perforation. Urticaria, angioedema and rashes of varying description. In rare cases, jaundice and thrombocytopenia, (usually reversible on withdrawal of flurbiprofen), aplastic anaemia and agranulocytosis.
Net price: 16 lozenges £2.
Supplier: Crookes Healthcare Ltd, PO Box 57, Central Park, Lenton Lane, Nottingham NG7 2LT. Tel 0115 9539922, fax 0115 9688722.
Legal class: POM.